National Coordinating Committee on Therapeutic Goods (NCCTG)
The National Coordinating Committee on Therapeutic Goods (NCCTG) was established by Order of the Federal Executive Council on 17 March 1971. The 1971 Order was revoked in October 1986 to facilitate the establishment of NCCTG as a committee of the Australian Health Ministers' Advisory Council (AHMAC).
NCCTG terms of reference
The Terms of Reference of the NCCTG are:
- to promote a coordinated and harmonised approach to the regulation and controls over therapeutic goods and poisons
- to provide policy guidance to the National Drugs and Poisons Schedule Committee
- to contribute to projects relevant to the regulation and control of therapeutic goods and poisons
- to share knowledge on emerging and important matters relevant to the regulation of therapeutic goods and poisons
- to report and make recommendations to the Australian Health Ministers' Advisory Council, via the Clinical/Technical and Ethical Principal Committee, as necessary.
NCCTG servicing
The Committee is serviced by the Therapeutic Goods Administration, a Division of the Australian Government Department of Health and Ageing.
NCCTG membership
The Committee is chaired by the National Manager of the Therapeutic Goods Administration and there is one other Australian Government appointed member (Branch Director of the Office of Devices, Blood and Tissues of the Therapeutic Goods Administration). One member from each State and Territory health authority is appointed by the relevant Minister responsible for the health portfolio of that State or Territory. One member is nominated by the New Zealand Ministry of Health. A delegate may attend meetings in the absence of a member. At the discretion of the chair, a member may invite an observer.
Member terms
There are no fixed terms for members. Neither sitting fees nor any other benefits are paid to members. Members receive fares and travelling allowance for attending meetings from their various health authorities.
NCCTG Members
Dr Rohan Hammett (Chair)
National Manager
Therapeutic Goods Administration
Ms Rita Maclachlan
Director, Office of Devices, Blood and Tissues
Therapeutic Goods Administration
Mr John Lumby
Chief Pharmacist, Pharmaceutical Services Branch
NSW Health
Mr Andrew Petrie
Director, Medicines and Pharmacy Services Unit
Queensland Health
Mr Keith Moyle
Manager, Drugs and Poisons Section
Department of Human Services, Victoria
Mr Murray Patterson
Chief Pharmacist
Department of Health, Western Australia
Ms Mary Sharpe (Acting Member)
Chief Pharmacist
Department of Health and Human Services, Tasmania
Mr Geoff Anderson (Acting Member)
Manager, Drugs of Dependence Unit
Drug and Alcohol Services, South Australia (DASSA)
Ms Helgi Stone
Chief Poisons Officer
Department of Health and Community Services, Northern Territory
Ms Jane Strang
Chief Pharmacist
ACT Health
TBA
New Zealand Ministry of Health
Mr P K Harrison (Secretary)
Office of Devices, Blood and Tissues
Therapeutic Goods Administration
Tel 02 6232 8636
Fax 02 6232 8687
NCCTG reports & reviews
- A discussion paper on regulation of extemporaneously prepared medicines in non-hospital pharmacies
<http://www.tga.gov.au/meds/extempcomp2.htm>
April 2008 - Review of the need for further regulation of extemporaneous compounding
<http://www.tga.gov.au/meds/extempcomp.htm>
September 2005 - Report to Health Ministers on a cost-benefit analysis of pharmacist only (S3) and pharmacy medicines (S2) and risk-based evaluation of the standards
<http://www.tga.gov.au/meds/s2s3report.htm>
August 2005